RE: Vacancies11 Nov 2020 14:09
Looking at the CV of Joanne Mason I'm a little surprised that she didn't join us at board level anyway. However as she's an addition and not a replacement she strengthens the board and provides another positive step.
It would seem that our Clarigen test will be seen as to slow at some point and faster tests will prevail. whether or not we will be involved in faster tests is, for me, a side issue. Yes, if we are that's good but I would prefer our pre-covid-19 business to be the main driver of growth.